NO883963L - Modifiserte plasminogenaktivatorer. - Google Patents

Modifiserte plasminogenaktivatorer.

Info

Publication number
NO883963L
NO883963L NO88883963A NO883963A NO883963L NO 883963 L NO883963 L NO 883963L NO 88883963 A NO88883963 A NO 88883963A NO 883963 A NO883963 A NO 883963A NO 883963 L NO883963 L NO 883963L
Authority
NO
Norway
Prior art keywords
dna
upa
region
fragment
amino acid
Prior art date
Application number
NO88883963A
Other languages
English (en)
Norwegian (no)
Other versions
NO883963D0 (no
Inventor
Giovanni Cassani
Marialuisa Nolli
Francesco Blasi
Federico Maria Robbiati
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO883963D0 publication Critical patent/NO883963D0/no
Publication of NO883963L publication Critical patent/NO883963L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
NO88883963A 1987-09-07 1988-09-06 Modifiserte plasminogenaktivatorer. NO883963L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878721023A GB8721023D0 (en) 1987-09-07 1987-09-07 Modified plasminogen activators

Publications (2)

Publication Number Publication Date
NO883963D0 NO883963D0 (no) 1988-09-06
NO883963L true NO883963L (no) 1989-03-08

Family

ID=10623401

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883963A NO883963L (no) 1987-09-07 1988-09-06 Modifiserte plasminogenaktivatorer.

Country Status (14)

Country Link
EP (1) EP0308716A3 (fr)
JP (1) JPH01117785A (fr)
KR (1) KR890005267A (fr)
CN (1) CN1033070A (fr)
AU (1) AU2196688A (fr)
DK (1) DK491988A (fr)
FI (1) FI883943L (fr)
GB (1) GB8721023D0 (fr)
HU (1) HUT47975A (fr)
IL (1) IL87638A (fr)
NO (1) NO883963L (fr)
NZ (1) NZ226050A (fr)
PT (1) PT88436B (fr)
ZA (1) ZA886401B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098840A (en) * 1986-07-03 1992-03-24 The Green Cross Corporation Human prourokinase mutants
AU5515790A (en) * 1989-05-18 1990-11-22 Green Cross Corporation, The Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor
CA2025181A1 (fr) * 1989-10-12 1991-04-13 William G. Weisburg Sondes a l'acide nucleique et methodes pour la detection des champignons
JPH0595786A (ja) * 1991-10-07 1993-04-20 Green Cross Corp:The 変異ヒトプロウロキナーゼ
US6120765A (en) * 1993-04-02 2000-09-19 Shiseido Co. Ltd. Urokinase plasminogen activator fragments
EP1879462B1 (fr) 2005-04-19 2022-03-09 Archer-Daniels-Midland Company Methode de preparation d'une composition de fibres non caloriques solubles
ATE530644T1 (de) 2006-07-05 2011-11-15 Catalyst Biosciences Inc Protease-screening-verfahren und dadurch identifizierte proteasen
DK2117571T3 (en) 2006-12-08 2017-05-08 Monopar Therapeutics Inc Urokinase-type plasminogen activator receptor epitope

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149786A (da) * 1985-04-04 1986-10-04 Beecham Group Plc Proteolytisk enzym
JPH0761266B2 (ja) * 1986-07-03 1995-07-05 株式会社ミドリ十字 変異ヒトプロウロキナ−ゼ
EP0266032A1 (fr) * 1986-08-29 1988-05-04 Beecham Group Plc Enzyme fibrinolytique modifiée
AU1295088A (en) * 1987-01-30 1988-08-24 American Home Products Corporation Des-epidermal growth factor plasminogen activators

Also Published As

Publication number Publication date
HUT47975A (en) 1989-04-28
FI883943A7 (fi) 1989-03-08
EP0308716A3 (fr) 1989-06-14
AU2196688A (en) 1989-06-08
PT88436A (pt) 1989-07-31
CN1033070A (zh) 1989-05-24
IL87638A (en) 1993-04-04
EP0308716A2 (fr) 1989-03-29
FI883943L (fi) 1989-03-08
KR890005267A (ko) 1989-05-13
FI883943A0 (fi) 1988-08-26
NZ226050A (en) 1991-06-25
JPH01117785A (ja) 1989-05-10
GB8721023D0 (en) 1987-10-14
PT88436B (pt) 1992-11-30
ZA886401B (en) 1989-07-26
IL87638A0 (en) 1989-01-31
DK491988A (da) 1989-03-08
NO883963D0 (no) 1988-09-06
DK491988D0 (da) 1988-09-05

Similar Documents

Publication Publication Date Title
KR970002166B1 (ko) 단백질 c를 암호화하는 dna 서열, 이를 함유하는 재조합 벡터, 재조합 벡터를 함유하는 포유동물 세포 및 단백질 c를 제조하는 방법
CA2024607C (fr) Methode de production d'adn recombinant et cellules hote
BG60253B2 (bg) Човешки тъканен плазминогенен активатор
JP2605155B2 (ja) 新規なヒト組織プラスミノーゲンアクチベーター変異体および方法
Fen et al. Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor
US5869314A (en) Tissue plasminogen activators and derivatives thereof as produced by recombinant means
JP2645237B2 (ja) ハイブリッドプラスミノーゲンアクチベータをコードする遺伝子
Weidle et al. Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells
NO883963L (no) Modifiserte plasminogenaktivatorer.
JP3043403B2 (ja) ヒトプラスミノーゲン変異体を発現させる方法及びその原料
JPH0761262B2 (ja) 遺伝子操作による因子ＸＩＩＩ ａの製造法
EP0195592A2 (fr) Protéine facteur IX
US5185259A (en) Truncated human tissue plasminogen activator
AU644352B2 (en) Expression induction method employing mutant dhfr gene
Reddy et al. Expression of human uterine tissue-type plasminogen activator in mouse cells using BPV vectors
EP0299706A2 (fr) Activateur du plasminogène non glycosyte, et sa méthode de fabrication
NO882791L (no) Fremgangsmaate for fremstilling av enkeltkjede urokinase.
JPH04218383A (ja) プラスミド、形質転換された動物細胞及び異種蛋白質の製造方法
Weidle et al. Establishment of a temperature-inducible cell line for human plasminogen activator (tissue-type) by transfection of monkey cells with expression constructs
JPH022338A (ja) 真核細肪中での同時発現
KR20080036561A (ko) 조직 플라스미노겐 활성제의 재조합 형태의 제조 방법
BG60509B2 (bg) Човешки тъканен плазминогенен активатор
NO882051L (no) Mrna-stabilisering i dyreceller.